SAN DIEGO, CA – September 11, 2025 – PhenoVista Biosciences and Carolina Molecular announce a partnership to combine their complementary CRO service capabilities to expand client access to broader multi-omic data. PhenoVista is a premier provider of cell-based assay services, specializing in high-content imaging and analysis, including downstream machine learning and subsequent quantitative biology. The partnership with Carolina Molecular allows shared clients to complement the functional and phenotypic, cellular data with orthogonal, molecular readouts, including robust immunoassay technologies for detecting key protein markers and gene expression analysis using targeted qPCR assays or broader transcriptomic profiling via RNA sequencing. By combining Carolina Molecular’s molecular testing services with PhenoVista’s high-content imaging expertise, customers will have access to high-quality, multi-omic data to inform their drug discovery processes.